Maria G Ioannides

Title: Maria G Ioannides: Innovator in Cancer Immunotherapy

Introduction

Maria G Ioannides is a prominent inventor based in Athens, Greece. She has made significant contributions to the field of immunotherapy, particularly in the stimulation of T-lymphocytes for cancer treatment. Her innovative work has the potential to advance therapeutic strategies against various proliferative disorders.

Latest Patents

Maria G Ioannides holds a patent for "Methods and compositions for stimulating T-lymphocytes." This patent discloses methods, compositions, antibodies, and therapeutic kits designed to stimulate cytotoxic T-lymphocytes and generate immune responses against epitopes of protooncogenes. The patent describes novel peptides that have been shown to stimulate cytotoxic T-lymphocytes and act as antigens in the generation of oncogenic epitope-recognizing antibodies. Additionally, the methods outlined in the patent are applicable in treating various proliferative disorders and diagnosing HER-2/neu-containing cells. The patent also includes therapeutic kits that are useful in cancer treatment and the production of potential anti-cancer vaccines. Maria has 1 patent to her name.

Career Highlights

Maria G Ioannides is affiliated with the University of Texas System, where she continues her research and development in cancer immunotherapy. Her work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative therapeutic approaches.

Collaborations

Maria has collaborated with notable colleagues, including Bryan A Fisk and Constantin G Ioannides. These partnerships have contributed to the depth and breadth of her research, enhancing the impact of her work in the field.

Conclusion

Maria G Ioannides is a trailblazer in the realm of cancer immunotherapy, with her innovative patent paving the way for new treatment options. Her dedication to research and collaboration underscores her significant role in advancing medical science.